Insider trading window closes from Oct 1, 2026 ahead of Q2 and H1 FY26 results

Compliance View source PDF Explain this filing

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.9%Reaction day

₹2850.00

prior close

₹2852.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-0.6%-3.3% vs market

Pharmaceuticals peers, median of 173sector+0.5%-4.4% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Smallcap 250 and 4.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-1.2

15m

-1.3

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.9-0.6-3.3+0.5-4.4

Next day

-4.9-0.4-4.6-0.3-4.6

-8.4-1.5-6.8-1.3-7.0

-9.3-1.2-8.1-1.6-7.7

-6.0+0.2-6.2-1.0-5.0

-7.4+0.3-7.7-1.1-6.4

-13.7-1.6-12.1-3.2-10.5

15d

-21.6-5.6-15.9-7.2-14.4

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Caplin Point Laboratories has informed the stock exchanges that the trading window for dealing in company securities will remain closed from October 1, 2026, in line with SEBI insider trading regulations. The closure is to prevent insider trading during finalization of unaudited financial results for the quarter and half year ending September 30, 2026. The window will reopen 48 hours after the financial results are declared to the exchanges.

Likely market impact

Routine compliance notice. No insider trades reported. Insiders barred from trading till 48 hours after Q2 and H1 FY26 results are announced.